A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors
一项针对亚洲晚期实体瘤患者的pexidartinib（一种集落刺激因子1受体抑制剂）的I期研究
期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-019-00745-z
Lee, Jih-Hsiang; Chen, Tom Wei-Wu; Hsu, Chih-Hung; Yen, Yu-Hsin; Yang, James Chih-Hsin; Cheng, Ann-Lii; Sasaki, Shun-Ichi; Chiu, LiYin Lillian; Sugihara, Masahiro; Ishizuka, Tomoko; Oguma, Toshihiro; Tajima, Naoyuki; Lin, Chia-Chi
